目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Process
1.2.1 Information Procurement
1.3 Research Scope and Assumptions
1.4 Research Methodology
1.5 Objectives
1.5.1 Objective - 1
1.5.2 Objective - 2
1.5.3 Objective - 3
1.6 List to Data Sources

Chapter 2 Executive Summary
2.1 Executive Summary
2.2 Digital Therapeutics Snapshot
2.3 Digital Therapeutics Segment Snapshot
2.4 Digital Therapeutics Competitive Landscape Snapshot

Chapter 3 Digital Therapeutics Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.1.2 Ancillary market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.3 Increasing prevalence of chronic diseases
3.2.4 Increasing smartphone penetration in developed and developing countries
3.2.5 Cost-effectiveness of digital health technology for providers and patients
3.2.6 Increasing demand for integrated healthcare systems and patient-centric care
3.2.5 Market Restraint Analysis
3.2.6 Concerns over data protection & privacy
3.2.7 Reluctance in adoption by certain market stakeholders
3.2.7 Porter Five Force Analysis
3.2.8 Threat of New Entrants: Low
3.2.9 Competitive Rivalry: High
3.2.10 Threat of Substitutes: Low
3.2.11 Bargaining Power of Buyers: High
3.2.12 Bargaining Power of Suppliers: Low
3.2.13 Pestle Analysis
3.2.14 Political and legal
3.2.15 Economical & Social
3.2.16 Technological
3.3 Impact of COVID-19 on the Digital Therapeutics

Chapter 4 Digital Therapeutics Market: Application Estimates & Trend Analysis
4.1 Digital Therapeutics Market: Application Movement Analysis
4.2 Market Definition and Scope
4.3 Digital Therapeutics Market Estimates & Forecast, By Application (USD Million)
4.4 Diabetes
4.5 Obesity
4.6 CVD
4.7Smoking Cessation
4.8 CNS Diseases
4.9 OTHERS

Chapter 5 Digital Therapeutics Market: End-Use Estimates & Trend Analysis
5.1 Digital Therapeutics Market: End-Use Movement Analysis
5.2 Market Definition and Scope
5.3 Digital Therapeutics Market Estimates & Forecast, By End-Use (USD Million)
5.4 Patients
5.5 Providers
5.6 Payers
5.7 Employers
5.8 Other End-uses

Chapter 6 Digital Therapeutics: Regional Estimates & Trend Analysis, by Application, and End-Use
6.1 North America
6.1.1 Competitive Scenario
6.1.2 North America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million):
6.1.3 U.S.
6.1.3.1 Key Country Dynamics
6.1.3.2 Regulatory framework
6.1.3.3 U.S. Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.1.4 Canada
6.1.4.1 Key Country Dynamics
6.1.4.2 Regulatory framework
6.1.4.3 Canada Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2 Europe
6.2.1 Competitive Scenario
6.2.2 Europe Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.3 UK
6.2.3.1 Key Country Dynamics
6.2.3.2 Regulatory framework
6.2.3.3 UK Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.4 Germany
6.2.4.1 Key Country Dynamics
6.2.4.2 Regulatory framework
6.2.4.3 Germany Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.5 France
6.2.5.1 Key Country Dynamics
6.2.5.2 Regulatory framework
6.2.5.3 France Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.6 Spain
6.2.6.1 Key Country Dynamics
6.2.6.2 Regulatory framework
6.2.6.3 Spain Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.7 Italy
6.2.7.1 Key Country Dynamics
6.2.7.2 Regulatory framework
6.2.7.2 Italy Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.8 Denmark
6.2.8.1 Key Country Dynamics
6.2.8.2 Regulatory framework
6.2.8.3 Denmark Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.9 Sweden
6.2.9.1 Key Country Dynamics
6.2.9.2 Regulatory framework
6.2.9.3 Sweden Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.10 Norway
6.2.10.1 Key Country Dynamics
6.2.10.2 Regulatory framework
6.2.10.3 Norway Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3 Asia Pacific
6.3.1 Competitive Scenario
6.3.2 Asia Pacific Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.3 Japan
6.3.3.1 Key Country Dynamics
6.3.3.2 Regulatory framework
6.3.3.3 Japan Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.4 China
6.3.4.1 Key Country Dynamics
6.3.4.2 Regulatory framework
6.3.4.3 China Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.5 India
6.3.5.1 Key Country Dynamics
6.3.5.2 Regulatory framework
6.3.5.3 India Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.6 Australia
6.3.6.1 Key Country Dynamics
6.3.6.2 Regulatory framework
6.3.6.3 Australia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.7 South korea
6.3.7.1 Key Country Dynamics
6.3.7.2 Regulatory framework
6.3.7.3 South korea Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.8 Thailand
6.3.8.1 Key Country Dynamics
6.3.8.2 Regulatory framework
6.3.8.3 ThailandDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Latin America
6.4.1 Competitive Scenario:
6.4.2 Latin America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3 Brazil
6.4.3.1 Key Country Dynamics
6.4.3.2 Regulatory framework
6.4.3.3 BrazilDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4 Mexico
6.4.4.1 Key Country Dynamics
6.4.4.2 Regulatory framework
6.4.4.3 MexicoDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5 Argentina
6.4.5.1 Key Country Dynamics
6.4.5.2 Regulatory framework
6.4.5.2 Argentina Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 MEA
6.5.1 COMPETITIVE SCENARIO
6.5.2 MEA Digital Therapeutics Market Estimates And ForecastsS, 2018 - 2030 (USD Million)
6.5.3 South Africa
6.5.3.1 Key Country Dynamics
6.5.3.2 Regulatory framework
6.5.3.3 South Africa Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4 Saudi arabia
6.5.4.1 Key Country Dynamics
6.5.4.2 Regulatory framework
6.5.4.3 Saudi arabia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5 UAE
6.5.5.1 Key Country Dynamics
6.5.5.2 Regulatory framework
6.5.5.3 UAE Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6 Israel
6.5.6.1 Key Country Dynamics
6.5.6.2 Regulatory framework
6.5.6.3 Israel Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.7 Kuwait
6.5.7.1 Key Country Dynamics
6.5.7.2 Regulatory framework
6.5.7.3 KuwaitDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis
7.1 Heat Map Analysis
7.2 Participant Categorization
7.2.1 Company Categorization Analysis

Chapter 8 Company Profile
8.1. OMADA Health, Inc.
8.2. Welldoc, Inc.
8.3. 2Morrow, Inc.
8.4. Teladoc Health, Inc.
8.5. Propeller Health
8.6. CANARY HEALTH
8.7. Noom, Inc.
8.8. Fitbit, LLC
8.9. Pear Therapeutics, Inc.
8.10. Akili Interactive Labs, Inc.
8.11. HYGIEIA
8.12. DarioHealth, Corp.
8.13. GAIA AG
8.14. BigHealth
8.15. Limbix Health, Inc.
8.16 Key Strategies Adopted by Players Include:
8.16.1 Expansion
8.16.2 Acquisition
8.16.3 Collaborations
8.16.4 Others

List of Tables
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 North America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 4 North America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 5 North America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 7 U.S. macro dynamics
TABLE 8 U.S. digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 9 U.S. digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 10 Canada macro dynamics
TABLE 11 Canada digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 12 Canada digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 13 Europe digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 14 Europe digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 15 Europe digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 16 UK macro dynamics
TABLE 17 UK digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 18 UK digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 19 Germany macro dynamics
TABLE 20 Germany digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 21 Germany digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 22 France macro dynamics
TABLE 23 France digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 24 France digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 25 Italy macro dynamics
TABLE 26 Italy digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 27 Italy digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 28 Spain macro dynamics
TABLE 29 Spain digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 30 Spain digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 31 Denmark macro dynamics
TABLE 32 Denmark digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 33 Denmark digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 34 Sweden macro dynamics
TABLE 35 Sweden digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 36 Sweden digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 37 Norway macro dynamics
TABLE 38 Norway digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 39 Norway digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 40 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 41 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 42 Asia Pacific digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 43 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018 - 2030 (USD Million)
TABLE 44 Japan macro dynamics
TABLE 45 Japan digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 46 Japan digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 47 China macro dynamics
TABLE 48 China digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 49 China digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 50 India macro dynamics
TABLE 51 India digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 52 India digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 53 Australia Macro dynamics
TABLE 54 Australia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 55 Australia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 56 Thailand macro dynamics
TABLE 57 Thailand digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 58 Thailand digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 59 South Korea macro dynamics
TABLE 60 South Korea digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 61 South Korea digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 62 Latin America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 63 Latin America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 64 Latin America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 65 Brazil macro dynamics
TABLE 66 Brazil digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 67 Brazil digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 68 Mexico macro dynamics
TABLE 69 Mexico digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 70 Mexico digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 71 Argentina macro dynamics
TABLE 72 Argentina digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 73 Argentina digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 74 MEA digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
TABLE 75 MEA digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 76 MEA digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 77 South Africa macro dynamics
TABLE 78 South Africa digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 79 South Africa digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 80 Saudi Arabia Macro dynamics
TABLE 81 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 82 Saudi Arabia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 83 UAE Macro dynamics
TABLE 84 UAE digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 85 UAE digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 86 Israel Macro dynamics
TABLE 87 Israel digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 88 Israel digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 89 Kuwait Macro dynamics
TABLE 90 Kuwait digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
TABLE 91 Kuwait digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 92 Key companies undertaking expansions
TABLE 93 Key companies undertaking acquisitions
TABLE 94 Key companies undertaking collaborations

List of Figures
FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Estimation methodology
FIG. 4 Data triangulation techniques
FIG. 5 Primary research pattern
FIG. 6 Market research approaches
FIG. 7 Value-chain-based sizing & forecasting
FIG. 8 QFD modeling for market share assessment
FIG. 9 Market formulation & validation
FIG. 10 Commodity flow analysis
FIG. 11 Digital therapeutics market snapshot, 2023 (USD Million)
FIG. 12 Segment snapshot
FIG. 13 Competitive landscape snapshot
FIG. 14 Parent market outlook
FIG. 15 Ancillary market outlook
FIG. 16 Digital Therapeutics market dynamics
FIG. 17 Digital therapeutics market driver impact
FIG. 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
FIG. 19 Top countries by smartphone users, 2021
FIG. 20 Digital therapeutics market restraint impact
FIG. 21 Market participation categorization
FIG. 22 Market leaders and innovators
FIG. 23 Company market position analysis
FIG. 24 Major deals & strategic alliances analysis
FIG. 25 COVID-19 confirmed cases around the world (March 2020- October 2021)
FIG. 26 Digital therapeutics market: Application movement analysis
FIG. 27 Digital therapeutics Market: Application dashboard
FIG. 28 Global diabetes market, 2018 - 2030 (USD Million)
FIG. 29 Global obesity market, 2018- 2030 (USD Million)
FIG. 30 Global CVD market, 2018- 2030 (USD Million)
FIG. 31 Global respiratory diseases market, 2018 - 2030 (USD Million)
FIG. 32 Global smoking cessation market, 2018 - 2030 (USD Million)
FIG. 33 Global CNS diseases market, 2018- 2030 (USD Million)
FIG. 34 Global others market, 2018- 2030 (USD Million)
FIG. 35 Digital therapeutics market: End-use movement analysis
FIG. 36 Digital therapeutics market: End-use dashboard
FIG. 37 Global patients market, 2018- 2030 (USD Million)
FIG. 38 Global providers market, 2018 - 2030 (USD Million)
FIG. 39 Global payers market, 2018 - 2030 (USD Million)
FIG. 40 Global employers market, 2018 - 2030 (USD Million)
FIG. 41 Global other end-user market, 2018- 2030 (USD Million)
FIG. 42 Regional marketplace: Key takeaways
FIG. 43 North America: SWOT analysis
FIG. 44 North America digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 45 U.S. digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 46 Canada digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 47 Europe: SWOT analysis
FIG. 48 Europe digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 49 UK digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 50 Germany digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 51 France digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 52 Italy digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 53 Spain digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 54 Sweden digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 55 Norway digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 56 Denmark digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 57 Asia Pacific: SWOT analysis
FIG. 58 Asia Pacific Digital Therapeutics market, 2018 - 2030 (USD Million)
FIG. 59 Japan digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 60 China digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 61 India digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 62 Australia digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
FIG. 63 South Korea digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 64 Thailand digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 65 Latin America: SWOT analysis
FIG. 66 Latin America digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 67 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 68 Brazil digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 69 Argentina digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 70 Middle East and Africa: SWOT analysis
FIG. 71 Middle East and Africa digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 72 South Africa digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 73 Saudi Arabia digital therapeutics market, 2018 - 2030 (USD Million)
FIG. 74 UAE digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
FIG. 75 Israel digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
FIG. 76 Kuwait digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
FIG. 77 Heat map analysis
FIG. 78 List of key emerging companies/technology disruptors/innovators